PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+24.32%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.14B
AUM Growth
+$1.14B
(+27%)
Cap. Flow
+$35.2M
Cap. Flow
% of AUM
3.09%
Top 10 Holdings %
Top 10 Hldgs %
66.05%
Holding
127
New
33
Increased
28
Reduced
22
Closed
24
Top Buys
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$69.5M |
| 2 |
CELG
Celgene Corp
CELG
|
$41.4M |
| 3 |
RPRX
Repros Therapeutics Inc.
RPRX
|
$34.8M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$23M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$19.4M |
Top Sells
| 1 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$107M |
| 2 |
Biogen
BIIB
|
$49.8M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$31.3M |
| 4 |
Lisata Therapeutics
LSTA
|
$25.5M |
| 5 |
STML
Stemline Therapeutics, Inc.
STML
|
$22.7M |
Sector Composition
| 1 | Healthcare | 82.97% |
| 2 | Financials | 0.01% |
| 3 | Consumer Staples | 0.01% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANAC
26
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $10.3M | 0.84% | 973,868 +391,033 | +67% | +$4.15M |
|
27
Amgen
AMGN
$155B
| $10.3M | 0.83% | +91,675 | New | +$10.3M |
|
|
CHTP
28
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
| $10.2M | 0.83% | 3,418,365 -1,240,315 | -27% | -$3.71M |
|
29
Sangamo Therapeutics
SGMO
$157M
| $10.1M | 0.82% | +965,000 | New | +$10.1M |
|
|
WBA
30
DELISTED
Walgreens Boots Alliance
WBA
| $10.1M | 0.82% | +187,870 | New | +$10.1M |
|
|
NPSP
31
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $9.73M | 0.79% | 305,762 -256,638 | -46% | -$8.16M |
|
32
Vanda Pharmaceuticals
VNDA
$279M
| $9.51M | 0.77% | +868,500 | New | +$9.51M |
|
|
WCG
33
DELISTED
Wellcare Health Plans, Inc.
WCG
| $9.21M | 0.75% | 132,081 +131,696 | +34,207% | +$9.18M |
|
34
Ionis Pharmaceuticals
IONS
$6.79B
| $7.24M | 0.59% | +192,800 | New | +$7.24M |
|
|
ECYT
35
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $5.58M | 0.45% | 418,715 +349,909 | +509% | +$4.66M |
|
|
ITMN
36
DELISTED
INTERMUNE INC
ITMN
| $4.61M | 0.37% | 300,000 | – | – |
|
|
IMMU
37
DELISTED
Immunomedics Inc
IMMU
| $4.57M | 0.37% | 737,505 -1,639 | -0.2% | -$10.2K |
|
|
STML
38
DELISTED
Stemline Therapeutics, Inc.
STML
| $4.09M | 0.33% | 90,208 -501,442 | -85% | -$22.7M |
|
|
ARRY
39
DELISTED
Array Biopharma Inc
ARRY
| $3.56M | 0.29% | 572,870 +553,550 | +2,865% | +$3.44M |
|
|
ATHX
40
DELISTED
Athersys, Inc. Common Stock
ATHX
| $3.53M | 0.29% | 2,150,117 -1,329,089 | -38% | -$2.18M |
|
41
Anika Therapeutics
ANIK
$135M
| $3.44M | 0.28% | +144,067 | New | +$3.44M |
|
|
INFI
42
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $3.4M | 0.28% | 195,155 +83,215 | +74% | +$1.45M |
|
43
EyePoint Pharmaceuticals
EYPT
$797M
| $3.17M | 0.26% | +772,000 | New | +$3.17M |
|
44
Verastem
VSTM
$569M
| $3M | 0.24% | +241,065 | New | +$3M |
|
|
MZOR
45
DELISTED
Mazor Robotics Ltd.
MZOR
| $2.99M | 0.24% | +177,078 | New | +$2.99M |
|
|
MDVN
46
DELISTED
MEDIVATION, INC.
MDVN
| $2.89M | 0.23% | +48,250 | New | +$2.89M |
|
|
47
Lisata Therapeutics
LSTA
$19.9M
| $2.84M | 0.23% | 331,593 -2,984,345 | -90% | -$25.5M |
|
|
SPNC
48
DELISTED
Spectranetics Corp
SPNC
| $2.59M | 0.21% | 154,079 -183,718 | -54% | -$3.09M |
|
49
DexCom
DXCM
$29.5B
| $2.05M | 0.17% | +72,550 | New | +$2.05M |
|
|
KERX
50
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $2.02M | 0.16% | 200,000 +150,000 | +300% | +$1.51M |
|